Breaking News
Get 60% Off 0
⏳ Final hours! Save up to 60% OFF InvestingPro
CLAIM SALE
Close

Clariane SE (KORI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.70 -0.04    -2.30%
15:25:36 - Delayed Data. Currency in EUR
Type:  Equity
Market:  Germany
ISIN:  FR0010386334 
S/N:  A0LE05
  • Volume: 52
  • Bid/Ask: 1.70 / 1.71
  • Day's Range: 1.70 - 1.71
Clariane SE 1.70 -0.04 -2.30%

Clariane SE Company Profile

 
Explore the Clariane SE company profile for core details about Clariane SE, assess Clariane SE company details, including a description of the company, key contact information, and insights into the top executives. Discover the company's operations and leadership to better understand its role in the industry.
IndustryHealthcare Providers & Services
SectorHealthcare
Employees

56000

Equity Type

ORD

Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers home care, support, and hospitalization services. It operates approximately health care facilities and networks in France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom. The company was formerly known as Korian and changed its name to Clariane SE in June 2023. Clariane SE was founded in 2001 and is headquartered in Paris, France.

Contact Information

Address 21 - 25 rue Balzac
Paris, 75008
France
Phone 33 1 55 37 52 00
Fax -

Top Executives

Name Age Since Title
Sophie Boissard 52 2016 CEO & Director
Jean-Pierre Duprieu 70 2016 Independent Chairman of the Board
Jean-Francois Brin 58 2019 Independent Director
Anne Ramon 55 2018 Director
Markus Muschenich 63 2017 Independent Director
Florence Barjou 51 2022 Director
Marie-Christine Leroux 63 2019 Employee Representative Director
Marie Sylvia Metayer 64 2024 Independent Non-Executive Director
Anne Lalou 61 2014 Independent Director
Guillaume Bouhours 48 2021 Independent Director
Matthieu Lance 56 2024 Director
Jean-Bernard Lafonta 62 2024 Director
Patricia Damerval 60 2024 Independent Director
Philippe Leveque 65 2022 Independent Director
Gilberto Antonio Nieddu 35 2022 Employee Representative Director
Julie Le Goff - 2024 Director
Ondrej Novak - 2024 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

KORI Comments

Write your thoughts about Clariane SE
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email